Provider Alert Coverage Changes For GLP-1 Weight Loss Medication By National Insurance Company glp1 [long term diet pills]

Provider Alert Coverage Changes For GLP-1 Weight Loss Medication By National Insurance Company glp1 [long term diet pills]

| 1h 28m 28s | Video has closed captioning.

PROVIDER ALERT! Major announcement from Blue Cross Blue Shield of Michigan regarding Weight Loss Medication Coverage with Zepbound, Saxenda, and Wegovy. Coverage for weight loss medication is being discontinued. It's expected that this new development might have a domino effect on Healthcare Coverage for Obesity Management and Weight Loss. 00:00 Introduction 00:54 Pending Insurance Changes For Those Taking GLP Medications 01:30 Letter Sent Out By BC/BS Michigan for Participants Taking GLP-1 Medications 02:15 Fully Insured Commercial Members Impacted 03:33 Prior Authorizations May Be Impacted 04:58 New Prior Authorizations May Be Required 06:40 Authorization Window of Time Limited 06:55 Criteria For New Prior Authorization All current authorizations for these medications for fully insured large group commercial members under BC/BS Michigan will expire July 31, 2024, and the following new criteria will apply: The member must be 18 years or older and have a body mass index of 35 or higher. The medication must be prescribed by a health care provider who has an established relationship with the member and has seen the member in person. The prescriber must document the member’s current baseline weight (within 30 days). The prescriber must document the member’s active participation in a lifestyle modification program (working with a coach, tracking food and exercising) for a minimum of six months before the prior authorization request. The prescriber will no longer be able to simply attest to a member’s participation. Without this documentation, the request will be denied. The member must enroll and participate in the Teladoc® Health program for weight management. This program, at no cost to eligible members, offers easy-to-use tools and support. The prescriber must submit documentation of the member’s active participation, or the request will be denied. Zepbound Journey With Ang - Schweb Network Blue Cross Blue Shield Drops Coverage of GLP-1 Obesity Drugs Video: From Blue Cross Blue Shield (Read here): Real World Trends from Blue Cross Blue Shield: Online Weight Loss Doctor: Plush Care Please subscribe and join me as I take you with me on my weight loss adventure after being off of Mounjaro for one year and now beginning another phase of my journey with Wegovy. While also implementing lifestyle changes. A little bit about me I am 60 years old and I was diagnosed as a pre-diabetic September 2022. I’ve been on a journey to see if I could reverse my insulin resistance; lower my A1c; and increase my insulin sensitivity. I am excited to share with you my journey. IG: @lifestyle_for_living Continuous Glucose Monitor www.signoshealth.com --------------------------------------------------------------------------------------------------------------------------------------------------- WEIGHT LOSS OVER 50 WOMEN OVER 50 WEIGHT LOSS TIRZEPATIDE WEIGHT LOSS GLP-1 MEDICATION JOURNEY ZEPBOUND WEIGHT LOSS WEIGHT LOSS MOTIVATION OVER 50 HEALTHY LIFESTYLE OVER 50 SELF-CARE DURING WEIGHT LOSS MATURE WOMEN WEIGHT LOSS WEIGHT LOSS TIPS FOR WOMEN GLP-1 WEIGHT LOSS JOURNEY TIRZEPATIDE FOR WOMEN MATURE WOMEN FITNESS OVER 50 HEALTH TIPS WOMEN’S HEALTH OVER 50 SUSTAINABLE WEIGHT LOSS HOLISTIC WEIGHT LOSS OVER 50 ANTI-AGING AND WEIGHT LOSS HEALTHY HABITS FOR MATURE WOMEN GLP-1 WEIGHT LOSS TIPS #wegovy #wegovyjourney #glp1 #glp #insulinresistance #semaglutide #semaglutideweightloss #saxenda #zepbound